SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QMDC --- QuadraMed Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DTRock who wrote (24)5/1/1999 10:54:00 AM
From: Sprucegoose   of 59
 
Well, it's been quite some time since I looked at this board. Most my time has been spent on the Yahoo-Quadramed board which has been quite active of late. Anyway, I thought I'd post the following message from the Yahoo board that was posted by the Remington Fund's manager. He's been quite good at calling the latest moves on Quad.

"...Being that the following was covered in a regional newspaper I thought I should post some of the highlights as it is improbable that the article will be picked up
by the national wires.

First, I would like to say that Mr Goose (post 1442) pretty much summarized my feelings about the conference call and subsequent pronouncements of an
excellent quarter.... which it was. There will be some lag time before some of the market makers and sector funds jump back into the market however, many of
these entities have a decent cash reserve and will get back in. Obviously, it is my feeling that Quadramed will play a major role in moving the entire sector out
of the current depressed state.

The news article, which was published in the Marin IJ this evening (29 April 1999) had some very telling quotes from some of the major players in the field.
Basically, all those analysts interviewed had good things to say not only about the first quarter but, more importantly, the entire fiscal year ahead. The two most
interesting comments came from Make Clulow of CIBC Oppenheimer in New York and Mark Mulcahy an analyst at Volpe Brown. Clulow stated that, '...overall, it
was a strong quarter (for Quadramed)...'. Both agreed that '...they (Quadramed) will definitely be one of the dominant players in the industry in the long
term....'. Mulcahy went on to say, '...although that call (the last conference call that resulted in the massive down grading of the stock)...dented our confidence in
our model for the quarter and the year, these strong results (announced in the last conference call).. should go a long way to reassuring us and should dispel
much of the uncertainty that has surrounded this stock for the last few months....'.

The Remington Fund has always been a fundamental investor. The fact of the matter is, is that Quadramed has the necessary fundamentals to prove a winner. That
is why, over the past several weeks, we have more than doubled our position.

Ross Pascall
ross@remingtongrp.com
Remington Group (USA)
Tel: 1(415) 435 7000
URL: Remingtongrp.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext